Case Studies

Curated Regulatory Intelligence Augmented by AI

Pharma and Biotech

Pharma Giant Elevated Regulatory Change Monitoring with RegAlert

The usage of dietary supplements and herbal medicine products continues to rise in several countries. However, the context of their usage varies widely across countries. While some restrict supplement use to general health and well-being, others allow...

Pharma and Biotech

Boosting Claims for a Health Product Launch

Read the case study and learn how a major healthcare company successfully optimized their product launch and boosted claims to make it more compelling to consumers. Objective A major healthcare company wanted to validate its regulatory strategy...

Pharma Giant Elevates Regulatory Change Monitoring With Regalert

Pharma and Biotech

Driving Pharmaceutical Regulatory Intelligence for Better Decision Making

Results The company gained increased visibility into the regulatory landscape impacting their product categories, along with enhanced agility and confidence in risk management and decision-making processes based on industry trends and foresight. Book a demo to learn...

Pharma and Biotech

Anticipating Regulatory Risks and Opportunities in Consumer Health Industry

Read the case study and learn from this practical example how to anticipate regulatory risks and opportunities in the consumer health and dietary supplements industry using RegASK’s cutting-edge technology tool. Challenge The client, a leading consumer health...

Pharma and Biotech

Decentralized Clinical Trials: How CROs Can Benefit from RegASK Solutions

As the COVID-19 pandemic continues to disrupt clinical research, there is an increased need from the pharmaceutical and CRO industry to implement decentralized or hybrid clinical trials (DCTs) for improving clinical trial efficiency. Read our case study...

Post How Real World Evidence Supported Claim Substantiation On Otc Product In Europe And Usa

Pharma and Biotech

How Real-World Evidence Supported Claim Substantiation on OTC Product in Europe and the USA

A leader in the pharmaceutical industry wanted to leverage real-world evidence to bolster the claims of an over the counter (OTC) product in the E.U. and U.S. markets. Indeed, as researchers collect real-world evidence, they can examine...

Pharma and Biotech

Market Entry to Mexico for a Health Product

Demand: Evaluating the Likelihood of Product Certification in the Mexican Market A large Chinese health-products company sought expansion into the Mexican market. The company requested RegASK’s assistance in determining the feasibility of gaining market entry into...

Fast turnaround. Expert Guidance. Cost efficient.